A common gout drug may prevent the progression of coronary disease, new research from Harry Perkins Institute of Medical Research and GenesisCare has found.
A common gout drug may prevent the progression of coronary disease, new research from Harry Perkins Institute of Medical Research and GenesisCare has found.